• 中国中文核心期刊
  • 中国科学引文数据库核心期刊
  • 中国科技核心期刊
  • 中国高校百佳科技期刊
高级检索

复方氨基酸注射液(18AA-Ⅱ)中甲硫氨酸氧化杂质的研究

邵天舒, 周长明, 李辉, 郭雷

邵天舒, 周长明, 李辉, 郭雷. 复方氨基酸注射液(18AA-Ⅱ)中甲硫氨酸氧化杂质的研究[J]. 中国药科大学学报, 2021, 52(6): 713-718. DOI: 10.11665/j.issn.1000-5048.20210609
引用本文: 邵天舒, 周长明, 李辉, 郭雷. 复方氨基酸注射液(18AA-Ⅱ)中甲硫氨酸氧化杂质的研究[J]. 中国药科大学学报, 2021, 52(6): 713-718. DOI: 10.11665/j.issn.1000-5048.20210609
SHAO Tianshu, ZHOU Changming, LI Hui, GUO Lei. Oxidized related substance of methionine in compound amino acid injection (18AA-Ⅱ)[J]. Journal of China Pharmaceutical University, 2021, 52(6): 713-718. DOI: 10.11665/j.issn.1000-5048.20210609
Citation: SHAO Tianshu, ZHOU Changming, LI Hui, GUO Lei. Oxidized related substance of methionine in compound amino acid injection (18AA-Ⅱ)[J]. Journal of China Pharmaceutical University, 2021, 52(6): 713-718. DOI: 10.11665/j.issn.1000-5048.20210609

复方氨基酸注射液(18AA-Ⅱ)中甲硫氨酸氧化杂质的研究

基金项目: 国家药品评价性抽验资助项目(2019年)

Oxidized related substance of methionine in compound amino acid injection (18AA-Ⅱ)

Funds: This study was supported by the National Drug Evaluation Surveillance (2019)
  • 摘要: 建立柱前衍生-HPLC同时测定复方氨基酸注射液(18AA-Ⅱ)中甲硫氨酸亚砜和甲硫氨酸砜含量的方法,以此方法考察了155批样品中这两种杂质的含量,并对其产生的原因进行分析。采用邻苯二甲醛-巯基丙酸溶液柱前衍生高效液相色谱法,色谱柱为Agilent Poroshell 120 EC-C18,荧光检测器激发波长233 nm,发射波长441 nm,流动相A为醋酸钠/四氢呋喃溶液,流动相B为醋酸钠溶液-乙腈-甲醇(200∶400∶400)(梯度洗脱),流速为0.5 mL/min,柱温为40 ℃,进样体积8 μL。以此方法对2019年国家评价性抽验的155批样品中甲硫氨酸亚砜及甲硫氨酸砜的含量进行测定,并用顶空气体测定仪测定上述样品的残氧量。结果显示,甲硫氨酸亚砜、甲硫氨酸砜的检测质量浓度线性范围分别为0.128 1 ~ 10.250 0 μg/mL(r = 0.999 9)和0.261 0 ~ 10.440 0 μg/mL(r = 0.999 8);定量限分别为0.13和0.26 μg/mL,检测限分别为0.04和0.09 μg/mL;精密度、稳定性、重复性试验的RSD < 1.3%;回收率分别为98.00% ~ 100.79%(RSD = 1.15%,n = 9)和98.19% ~ 102.31%(RSD = 1.33%,n = 9)。不同厂家的样品中甲硫氨酸氧化产物含量差异较大,样品中甲硫氨酸氧化产物含量与残氧量具有一定相关性,但与样品中抗氧剂焦亚硫酸钠添加量并无明显相关性。本方法可有效监控复方氨基酸注射液(18AA-Ⅱ)中甲硫氨酸亚砜和甲硫氨酸砜的含量,在质量标准中增设甲硫氨酸氧化杂质的检查项很有必要,生产厂家应加强对产品残氧量的控制。
    Abstract: TA method for the content determination of methionine sulfoxide and methionine sulfone in compound amino acid injection (18AA-II) was established in order to investigate their level in 155 batches of this product, and to explore the reason for the generation of these two impurities.The determination was performed on an Agilent Poroshell 120 EC-C18 column with mobile phases of sodium acetate/tetrahydrofuran solution (A) and sodium acetate solution -acetonitrile-methanol (B, 200∶400∶400) (gradient elution) at the flow rate of 0.5 mL/min.The excitation wavelength and the emission wavelength of the fluorescence detector were 233 nm and 441 nm, respectively.The column temperature was 40 °C, and the injection volume was 8 μL.The contents of methionine sulfoxide and methionine sulfone from 155 batches of compound amino acid injection (18AA-II) was determined using this method, and the residual oxygen content was detected by headspace gas analyzer.The results showed that the linear range of methionine sulfoxide and methionine sulfone were 0.128 1-10.250 0 μg/mL (r = 0.999 9) and 0.261 0-10.440 0 μg/mL (r = 0.999 8), respectively.The limits of quantitation were 0.13 μg/mL and 0.26 μg/mL, respectively; the limits of detection were 0.04 μg/mL and 0.09 μg/mL, respectively.RSDs of precision, stability and repetitive test were all lower than 1.3%.The recoveries ranged 98.00%-100.79% (RSD = 1.15%, n = 9) and 98.19%-102.31% (RSD = 1.33%, n = 9).The content level of oxidized related substances from different manufacturers showed significant difference, showing relevance with the residual oxygen content to some extent, yet no significant correlation with the added amount of antioxygen (sodium pyrosulfite).The method is validated to be useful for the content control of methionine sulfoxide and methionine sulfone in compound amino acid injection (18AA-II).It is quite necessary to include the determination of oxidized related substance into the quality specification.Manufacturers should strengthen the control of remaining oxygen in their products.
  • [1] . Chin J New Drugs(中国新药杂志),2019,28(5):584-588.
    [2] Zhou M,Xiong X,Wang X,et al. Quality evaluation of amino acid injection(18AA)[J]. Drug Res(药物研究),2020,17(23):20-22.
    [3] Gao C,Li M,Wei JM,et al. Expert consensus on clinical use of compound amino acid injection[J]. Electron J Metab Nutr Cancer (肿瘤代谢与营养电子杂志),2019,6(2):183-189.
    [4] Joseph TD,Adnan AE. L-methionine-dl-sulfoxide metabolism and toxicity in freshly isolated mouse hepatocytes:gender differences and inhibition with aminooxyacetic acid[J]. Drug Metab Dispos,2008,36(11): 2252-2260.
    [5] Joseph TD,Adnan AE. The biochemical and toxicological significance of hypermethionemia: new insights and clinical relevance[J]. Expert Opin Drug Met,2010,6 (11):1333-1346.
    [6] Arad G,Kulka RG. Effects of glutamine,methionine sulfone and dexamethasone on rates of synthesis of glutamine synthetase in cultured hepatoma cells[J].Biochimica et BiophysicaActa,1978,544(1):153-162.
    [7] Chinese Pharmacopoeia Commission. Chinese Pharmacopoeia:part 2(中华人民共和国药典:二部)[S]. Beijing:China Medical Science Press,2020:811.
    [8] Xiao YX,Ni JH. The determination of met,metson and metsox in gelatins[J]. J Amino Acid(氨基酸杂志),1994,1:31-34.
    [9] Li L,Cui HY,Zhong JQ,et al. Simultaneous and direct determination of methionine sulfoxide and methionine sulfone in compound amino acid injection (18AA) by HPLC[J]. Chin J Anal Lab(分析试验室),2018,37(11):1309-1314.
    [10] Kan WN,Teng YK,Yang HW,et al. Simultaneous determination of 18 kinds of amino acids in compound amino acid injection by DTDPA-PITC combined with pre-column derivatization HPLC[J]. J China Pharm(中国药房),2014,25(12):1122-1125.
    [11] Wang Z,Feng F. Determination of 12 depression-related amino acids in rat plasma and brain tissue by HPLC with pre-column derivatization[J]. J China Pharm Univ(中国药科大学学报),2012,43(4) :345-349.
    [12] Chinese Pharmacopoeia Commission. Chinese Pharmacopoeia:part 4(中华人民共和国药典:四部)[S]. Beijing:China Medical Science Press,2020.
    [13] ICH.Q3B(R2):impurities in new drug products[EB/OL].2006.[2021-04-27]. https://database.ich.org/sites/default/files/Q3B%28R2%29%20Guideline.pdf
  • 期刊类型引用(3)

    1. 刘景坤,张斗胜,范慧红,廖海明. 首批L-甲硫氨酸亚砜国家药品对照品的研制. 药物分析杂志. 2024(08): 1373-1378 . 百度学术
    2. 吴小飞,刘丹杏,王宏亮,白玉. 复方氨基酸注射液仿制药药学研究的相关考虑. 中国新药杂志. 2023(21): 2134-2139 . 百度学术
    3. 郭雷,周长明,李辉,邵天舒. 复方氨基酸注射液(18AA-Ⅱ)有关物质2-磺基色氨酸的研究. 药物分析杂志. 2022(11): 2050-2055 . 百度学术

    其他类型引用(0)

计量
  • 文章访问数:  181
  • HTML全文浏览量:  14
  • PDF下载量:  520
  • 被引次数: 3
出版历程
  • 收稿日期:  2021-05-20
  • 修回日期:  2021-11-05
  • 刊出日期:  2021-12-24

目录

    /

    返回文章
    返回
    x 关闭 永久关闭